Unlike peripheral cancers, where the immune response can be suppressed via pathways like PD1/PD-L1 [20], GBM progression is shaped by the unique brain environment, including the blood–brain barrier and glial cell activity [21]. This evidence concerns the gene CD274 and glioblastoma.